NovoLog FlexPen and Risankizumab-rzaa topical
Determining the interaction of NovoLog FlexPen and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog FlexPen-Risedronate
- NovoLog FlexPen-Risedronate and Calcium
- NovoLog FlexPen-Risedronate Delayed Release
- NovoLog FlexPen-Risedronate Delayed-Release Tablets
- NovoLog FlexPen-Risedronate Sodium
- NovoLog FlexPen-Risedronate Tablets
- Risankizumab-rzaa topical-Novolog Injection
- Risankizumab-rzaa topical-NovoLog Mix 70/30
- Risankizumab-rzaa topical-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Risankizumab-rzaa topical-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Risankizumab-rzaa topical-NovoLog Mix 70/30 FlexPen
- Risankizumab-rzaa topical-NovoLog PenFill